Halberd Corporation: Infectious Disease Specialist Will Guide Halberd's Extracorporeal Elimination of Disease Antigens in Animals and Then Humans

JACKSON CENTER, PA / ACCESSWIRE / March 16, 2022 / Halberd Corporation (OTC PINK:HALB) announces its entry into the next stage of research. To guide it, having successfully eliminated the Top 10 Target

Related Keywords

Florida ,United States ,Montreal ,Quebec ,Canada ,Chicago ,Illinois ,Kostenloser Wertpapierhandel ,Williama Hartman ,Ravi Venkata Durvasula ,University Of New Mexico ,Twitter ,Research Funding ,Halberd Team ,Halberd Corporation ,Degrees In Biology At Mcgill University ,Infectious Diseases ,Mayo Clinic Florida ,Undergraduate Degrees ,Mcgill University ,Loyola University Stritch School ,New Mexico ,Research Funding Awards ,Private Securities Litigation Reform Act ,Halberd ,Corporation ,Nfectious ,Disease ,Specialist ,Hill ,Uide ,Extracorporeal ,Elimination ,Antigens ,Animals ,When ,Humans ,